0001104659-25-099416.txt : 20251015 0001104659-25-099416.hdr.sgml : 20251015 20251014205923 ACCESSION NUMBER: 0001104659-25-099416 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251015 DATE AS OF CHANGE: 20251014 EFFECTIVENESS DATE: 20251015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560796 FILM NUMBER: 251393243 BUSINESS ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631-240-8800 MAIL ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 D 1 primary_doc.xml X0708 D LIVE 0000744452 APPLIED DNA SCIENCES INC 50 HEALTH SCIENCES DRIVE STONY BROOK NY NEW YORK 11790 631-240-8800 DELAWARE PROHEALTH MEDICAL TECHNOLOGIES INC DCC ACQUISITIONS CORP PROHEALTH MEDICAL TECHNOLOGIES INC DCC ACQUISITION CORP DATALINK CAPITAL CORP/TX/ Corporation true Clay Shorrock 50 Health Sciences Drive STONY BROOK NY NEW YORK 11790 Executive Officer Chief Executive Officer Beth Jantzen 50 Health Sciences Drive STONY BROOK NY NEW YORK 11790 Executive Officer Chief Financial Officer Judith Murrah 50 Health Sciences Drive STONY BROOK NY NEW YORK 11790 Executive Officer Director Chairperson of the Board, Strategic Transition Advisor Yacov A. Shamash 50 Health Sciences Drive STONY BROOK NY NEW YORK 11790 Director Robert B. Catell 50 Health Sciences Drive STONY BROOK NY NEW YORK 11790 Director Joseph D. Ceccoli 50 Health Sciences Drive STONY BROOK NY NEW YORK 11790 Director Elizabeth M. Schmalz Shaheen 50 Health Sciences Drive STONY BROOK NY NEW YORK 11790 Director Biotechnology Decline to Disclose 06b false 2025-09-29 false true true true false 0 Lucid Capital Markets, LLC 000140345 None None 570 Lexington Avenue, 40th Floor NEW YORK NY NEW YORK 10022 AZ ARIZONA CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS KY KENTUCKY NY NEW YORK TX TEXAS VT VERMONT PR PUERTO RICO false 58000000 58000000 0 Reflects estimated proceeds from the sale of shares of the Company's common stock, par value $0.001 per share and/or pre-funded warrants and Series E Warrants, if all Series E Warrants were exercised. false 33 361745 0 725000 Includes a total gross amount of (i) $400,000 to be paid in a lump sum to Ms. Murrah on or before November 17, 2025; (ii) $175,000 to be paid as a one-time cash bonus to Mr. Shorrock; and (iii) $150,000 to be paid as a one-time cash bonus to Ms. Jantzen false APPLIED DNA SCIENCES INC /s/ Beth Jantzen Beth Jantzen Chief Financial Officer 2025-10-14